Literature DB >> 26910742

The impact of recent advances in genetics in understanding disease mechanisms underlying the long QT syndromes.

Stephen C Harmer, Andrew Tinker.   

Abstract

Long QT syndrome refers to a characteristic abnormality of the electrocardiogram and it is associated with a form of ventricular tachycardia known as torsade-de-pointes and sudden arrhythmic death. It can occur as part of a hereditary syndrome or can be acquired usually because of drug administration. Here we review recent genetic, molecular and cellular discoveries and outline how they have furthered our understanding of this disease. Specifically we focus on compound mutations, genome wide association studies of QT interval, modifier genes and the therapeutic implications of this recent work.

Entities:  

Mesh:

Year:  2016        PMID: 26910742     DOI: 10.1515/hsz-2015-0306

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  6 in total

Review 1.  Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.

Authors:  Arsen Uvelin; Jasmina Pejaković; Vesna Mijatović
Journal:  J Anesth       Date:  2017-02-22       Impact factor: 2.078

2.  Does knowledge of the mutation in hereditary long QT syndrome aid risk stratification?

Authors:  Andrew Tinker
Journal:  Eur Heart J       Date:  2021-12-07       Impact factor: 35.855

3.  Non-invasive phenotyping and drug testing in single cardiomyocytes or beta-cells by calcium imaging and optogenetics.

Authors:  Yu-Fen Chang; Connor N Broyles; Frances A Brook; Mark J Davies; Cameron W Turtle; Takeharu Nagai; Matthew J Daniels
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

4.  Genetic Basis and Prognostic Value of Exercise QT Dynamics.

Authors:  Stefan van Duijvenboden; Julia Ramírez; Michele Orini; Andrew Tinker; Patricia B Munroe; Pier D Lambiase; William J Young; Borbala Mifsud
Journal:  Circ Genom Precis Med       Date:  2020-06-11

5.  The contribution of non-coding regulatory elements to cardiovascular disease.

Authors:  Diego Villar; Stephanie Frost; Panos Deloukas; Andrew Tinker
Journal:  Open Biol       Date:  2020-07-01       Impact factor: 6.411

6.  Phosphatidylinositol-4,5-bisphosphate is required for KCNQ1/KCNE1 channel function but not anterograde trafficking.

Authors:  Alice A Royal; Andrew Tinker; Stephen C Harmer
Journal:  PLoS One       Date:  2017-10-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.